Actively Recruiting
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-12-19
1025
Participants Needed
4
Research Sites
623 weeks
Total Duration
On this page
Sponsors
M
Memorial Sloan Kettering Cancer Center
Lead Sponsor
C
Comprehensive Cancer Centre The Netherlands
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times, these conditions are a side effect of cancer treatment. Patients in the study will be asked to fill out at least one questionnaire about how they feel about their skin condition. If the patient needs to be treated for their skin condition, they will be asked to complete the same questionnaire when they return for a follow-up visit. The investigators hope the study will improve our understanding of how cancer patients feel about their skin conditions. They also hope this study helps them learn how to improve the way we treat skin conditions in cancer patients.
CONDITIONS
Official Title
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cancer patients and survivors with a pre-existing skin condition related to their cancer or cancer treatment, presenting for skin condition assessment or management
- Male or female patients aged 3 years and older
- Informed consent will be obtained following guidelines for minors
- First-grade adult family members, spouses, or caregivers of patients with Grade 2 or 3 or higher skin conditions related to cancer or its treatment, able to provide written informed consent
You will not qualify if you...
- Cognitive or psychiatric deficits that prevent providing written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
Actively Recruiting
2
Memorial Sloan Kettering Westchester
Harrison, New York, United States, 10604
Actively Recruiting
3
Memorial Sloan Kettering Suffolk- Hauppauge
Hauppauge, New York, United States, 11788
Actively Recruiting
4
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
E
Erica Lee, MD
CONTACT
S
Shamir Geller, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here